Kidney Transplant Rejection Market wird durch Behandlung (Immunosuppressive Drugs, Antibody-mediated Rejection Therapies), By Rejection Type (Chronic Rejection, Acute Rejection), By Diagnostic Approach (Biomarker-basierte Diagnostik, Genomics-based Diagnostics), By Therapeutics (Small Molecule Inhibitors, Americas, Biologic Europe, By Therapeutics). Der Bericht bietet den Wert (in Mrd. USD) für die oben genannten Segmente.
Zu den wichtigsten Akteuren des Nierentransplantationsmarktes gehören Eledon Pharmaceuticals, Sangamo Therapeutics, AlloVir, CSL Behring, Hansa Biopharma, Veloxis Pharmaceuticals, Novartis und Transplant Genomics.
Kidney Transplant Rejecting Market